Preanalytical conditions and circulating matrix metalloproteinases [11]

Transplantation

Volumn 79, Issue 6, 2005, Pages 745-746

  Verspaget, Hein W ^a   Kuyvenhoven, Johan Ph ^a   Van Hoek, Bart ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; EDETIC ACID; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; LIVER TRANSPLANTATION; PRIORITY JOURNAL; ZYMOGRAPHY;

EDETIC ACID; GRAFT REJECTION; HEPARIN; HUMANS; LIVER TRANSPLANTATION; MATRIX METALLOPROTEINASE 9;

EID: 16244375853     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147343.33801.35     Document Type: Letter

References (5)

1. Jung K, Laube C, Lein M, et al. Kind of sample as preanatytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin Chem 1998; 44: 1060.
2. Jung K, Lein M, Roemer A, Lichtinghagen R. Circulating gelatinase B (MMP-9) - the impact of the preanalytical step of blood collection. Matrix Biol 2002; 21: 381.
3. Kuyvenhoven JP, Verspaget HW, Gao Q, et al. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 2004; 77: 1646.
4. Kuyvenhoven JP, Molenaar IQ, Verspaget HW, et al. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb Haemost 2004; 91: 506.
5. Mannello F, Luchetti F, Canonico B, Papa S. Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases. Clin Chem 2003; 49: 1956.